About NeuroMetrix
NeuroMetrix is a company based in Woburn (United States) founded in 1996 by Shai N Gozani was acquired by ElectroCore in December 2024.. NeuroMetrix has raised $14.58 million across 6 funding rounds from investors including MIT, ElectroCore and 180 Degree Capital. The company has 26 employees as of December 31, 2023. NeuroMetrix offers products and services including Quell Fibromyalgia and DPNCheck. NeuroMetrix operates in a competitive market with competitors including Remedee Labs, Sky Medical Technology, Electromedical Technologies, Galvani Bioelectronics and Sublimed, among others.
- Headquarter Woburn, United States
- Employees 26 as on 31 Dec, 2023
- Founders Shai N Gozani
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurometrix, Inc.
-
Annual Revenue
$3.03 M-49as on Dec 31, 2024
-
Net Profit
$-6.53 M-48as on Dec 31, 2023
-
EBITDA
$-8.78 M-23as on Dec 31, 2024
-
Total Equity Funding
$14.58 M (USD)
in 6 rounds
-
Latest Funding Round
$21 M (USD), Post-IPO
Jun 03, 2016
-
Investors
MIT
& 9 more
-
Employee Count
26
as on Dec 31, 2023
-
Acquired by
ElectroCore
(Dec 17, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroMetrix
NeuroMetrix offers a comprehensive portfolio of products and services, including Quell Fibromyalgia and DPNCheck. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable neuromodulator to reduce fibromyalgia symptoms.
Rapid test for detecting peripheral neuropathies in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroMetrix
NeuroMetrix has successfully raised a total of $14.58M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $21 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $21.0M
-
First Round
First Round
(01 Jan 2003)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Post-IPO - NeuroMetrix | Valuation |
investors |
|
| Dec, 2015 | Amount | Post-IPO - NeuroMetrix | Valuation |
investors |
|
| May, 2015 | Amount | Post-IPO - NeuroMetrix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroMetrix
NeuroMetrix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include MIT, ElectroCore and 180 Degree Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Investments are made in life sciences firms across all stages.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on company buyouts
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroMetrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroMetrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurometrix Comparisons
Competitors of NeuroMetrix
NeuroMetrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Remedee Labs, Sky Medical Technology, Electromedical Technologies, Galvani Bioelectronics and Sublimed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Endorphin stimulation therapy for pain management is developed.
|
|
| domain | founded_year | HQ Location |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| domain | founded_year | HQ Location |
An electrotherapy device that helps reduce and eliminate chronic or acute pain
|
|
| domain | founded_year | HQ Location |
Implantable neuromodulation devices for chronic disease treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of pain management devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neurometrix
Frequently Asked Questions about NeuroMetrix
When was NeuroMetrix founded?
NeuroMetrix was founded in 1996 and raised its 1st funding round 7 years after it was founded.
Where is NeuroMetrix located?
NeuroMetrix is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Who is the current CEO of NeuroMetrix?
Shai N Gozani is the current CEO of NeuroMetrix. They have also founded this company.
Is NeuroMetrix a funded company?
NeuroMetrix is a funded company, having raised a total of $14.58M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $14.7M, raised on Jan 01, 2003.
How many employees does NeuroMetrix have?
As of Dec 31, 2023, the latest employee count at NeuroMetrix is 26.
What is the annual revenue of NeuroMetrix?
Annual revenue of NeuroMetrix is $3.03M as on Dec 31, 2024.
What does NeuroMetrix do?
NeuroMetrix develops wearable medical technology and point-of-care tests for chronic pain, nerve diseases, and sleep disorders. Products include Quell (wearable for pain relief), Sensus (neurostimulation device for diabetic neuropathy associated pain), DPN Check (test for diabetic neuropathy) and the Advance NCS platform for the performance of nerve conduction studies. Went public in 2004. Its Quell device stimulates the sensory nerves in the leg, with the signal traveling up to the brain. This signal in the brain releases endogenous opioids into the spine which provide relief from chronic pain.
Who are the top competitors of NeuroMetrix?
NeuroMetrix's top competitors include Remedee Labs, Sky Medical Technology and Electromedical Technologies.
What products or services does NeuroMetrix offer?
NeuroMetrix offers Quell Fibromyalgia and DPNCheck.
Who are NeuroMetrix's investors?
NeuroMetrix has 10 investors. Key investors include MIT, ElectroCore, 180 Degree Capital, Deerfield, and Delphi Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.